Aptevo Therapeutics Inc (APVO) is near the top in its industry group according to InvestorsObserver. APVO gets an overall rating of 59. That means it scores higher than 59 percent of stocks. Aptevo Therapeutics Inc gets a 92 rank in the Biotechnology industry. Biotechnology is number 107 out of 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Aptevo Therapeutics Inc Stock Today?
Aptevo Therapeutics Inc (APVO) stock is lower by -12.66% while the S&P 500 is higher by 0.56% as of 9:54 AM on Monday, Jun 21. APVO is lower by -$3.47 from the previous closing price of $27.36 on volume of 85,227 shares. Over the past year the S&P 500 is higher by 34.39% while APVO is higher by 305.77%. APVO lost -$7.67 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Aptevo Therapeutics Inc (APVO) Stock.
